Home › Trials › NCT06943742
Clinical trial Recruiting at 1 site Observational Ages 3 to 18

Evaluating magnetoencephalography for pediatric brain tumors

Official title: Non-Helium Magnetoencephalography for Clinical Management of Pediatric Brain Tumors : An Observational Cohort Study

Run by Guangzhou Women and Children's Medical Center · NCT06943742 · Data updated 2026-11-12

This study is testing if a special brain imaging technique called magnetoencephalography can help doctors find brain tumors in kids more accurately than regular scans like CT and MRI.

Quick facts

Study typeObservational
Ages3 Years to 18 Years
SexAll
Enrollment100 (estimated)
SponsorGuangzhou Women and Children's Medical Center
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedNovember 5, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedApril 24, 2025
Trial IDNCT06943742 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 3 to 18 years who have been clinically diagnosed with a brain tumor and can cooperate with MEG evaluations.

Probably not a fit

Patients with serious comorbidities, neurological or psychiatric disorders, or those unsuitable for surgical procedures may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study assesses the effectiveness of magnetoencephalography (MEG) in the preoperative evaluation of pediatric brain tumors. It aims to compare the localization accuracy of MEG with traditional imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI). Participants aged 3 to 18 years will undergo both MEG and CT/MRI examinations, with follow-up assessments at 1, 3, and 6 months post-surgery to evaluate the extent of tumor resection and overall quality of life. The study seeks to determine the clinical efficacy of MEG in guiding surgical decisions.

Why it matters

Potential benefit: If successful, this study could enhance the precision of preoperative assessments for pediatric brain tumors, potentially leading to better surgical outcomes.

How similar studies have gone: While the use of MEG in brain tumor assessment is promising, this specific approach has not been extensively tested in pediatric populations, making it a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Age range: 3-18 years old;
* Clinically diagnosed with brain tumor;
* Capable of cooperating with magnetoencephalography evaluation and recording.

Exclusion Criteria:

* Patients with serious comorbidities or neurological or psychiatric disorders that affect magnetoencephalography examination.
* Patients using drugs that affect central nervous system function;
* Patients who are not suitable for surgical procedures;
* Patients with progressive neurological disorders.

Where it's running

  • Guangzhou Women and Children's medical center
    Guangzhou, Guangdong, China     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Pediatric Brain Tumor 8Guangzhou Women and Children's Medical Center 19
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.